Autism and Clostridium tetani.

[1]  G. Fried,et al.  Synaptic vesicles and release of transmitters: new insights at the molecular level. , 1995, Acta physiologica Scandinavica.

[2]  R. Waring,et al.  Enzyme and sulphur oxidation deficiencies in autistic children with known food intolerances. , 1993 .

[3]  M. Iivanainen,et al.  Tetanus of Immunized Children , 1993, Developmental medicine and child neurology.

[4]  A. Shah,et al.  Diagnosis and treatment of Clostridium difficile colitis. , 1993, JAMA.

[5]  C. Wells,et al.  Clostridium tetani growth and toxin production in the intestines of germfree rats , 1983, Infection and immunity.

[6]  Tsaltas Mo.  A pilot study on allergic responses. , 1986 .

[7]  C. Gillberg,et al.  Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders , 1993, Biological Psychiatry.

[8]  N. Sugimoto,et al.  Blocking effects of tetanus toxin and its fragment [A-B] on the excitatory and inhibitory synapses of the spinal motoneurone of the cat. , 1989, Toxicon : official journal of the International Society on Toxinology.

[9]  G. Schiavo,et al.  [39] Tetanus and botulism neurotoxins: Isolation and assay , 1995 .

[10]  R. Tuchman,et al.  Autism and Associated Behavioral Disorders: Pharmacotherapeutic Intervention , 1995, The Annals of pharmacotherapy.

[11]  Karen L. Smith,et al.  Tetanus toxin-induced seizures in infant rats and their effects on hippocampal excitability in adulthood , 1995, Brain Research.

[12]  N. Crone,et al.  Severe tetanus in immunized patients with high anti‐tetanus titers , 1992 .

[13]  I. Rapin,et al.  Autistic children: diagnosis and clinical features. , 1991, Pediatrics.

[14]  G. Schiavo,et al.  Molecular mechanisms of action of bacterial protein toxins. , 1994, Molecular aspects of medicine.

[15]  M. Gratzl,et al.  Synaptobrevin cleavage by the tetanus toxin light chain is linked to the inhibition of exocytosis in chromaffin cells , 1994, FEBS letters.

[16]  F. Benfenati,et al.  Tetanus and Botulinum Neurotoxins Are Zinc Proteases Specific for Components of the Neuroexocytosis Apparatus a , 1994, Annals of the New York Academy of Sciences.

[17]  H. Jackson,et al.  Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats , 1989, Neuropharmacology.

[18]  M. Holodniy,et al.  Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Cordes,et al.  Single‐photon Emission Computed Tomography Investigations of Alternating Hemiplegia of Childhood , 1993, Developmental medicine and child neurology.

[20]  M. Kigawa,et al.  Some factors affecting isolation of Clostridium tetani from human and animal stools. , 1988, The Japanese journal of experimental medicine.

[21]  G. Nisticó,et al.  Effects of tetanus toxin after intracerebral microinjection are antagonized by drugs enhancing gabaergic transmission in adult fowls , 1984, Neuropharmacology.

[22]  S. Borriello,et al.  Clostridial disease of the gut. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. Francis,et al.  Lack of Change in Neurochemical Markers During the Postepileptic Phase of Intrahippocampal Tetanus Toxin Syndrome in Rats , 1990, Epilepsia.

[24]  C. Gillberg,et al.  Outcome and prognostic factors in infantile autism and similar conditions: A population-based study of 46 cases followed through puberty , 1987, Journal of autism and developmental disorders.

[25]  T. Helting,et al.  Toxicity of papain-digested tetanus toxin. Pathological effect of fragment B in the absence of spastic paralysis. , 1978, The Journal of biological chemistry.

[26]  M. Noppe,et al.  Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[27]  L. Simpson,et al.  Neuropharmacological characterization of fragment B from tetanus toxin. , 1985, The Journal of pharmacology and experimental therapeutics.

[28]  K. Miyamoto,et al.  Cytotoxic effect of the culture supernatant of Clostridium tetani. , 1982, Chemical & pharmaceutical bulletin.

[29]  L. Eaves,et al.  Subtypes of autism by cluster analysis , 1994, Journal of autism and developmental disorders.

[30]  Ogunyemi Ao.  The clinical recognition of subacute tetanus. , 1986 .

[31]  Christopher Gillberg,et al.  The biology of the autistic syndromes, 2nd ed. , 1992 .

[32]  A. Lipson.  INFECTING DOSE OF SALMONELLA , 1976, The Lancet.

[33]  W. Moore,et al.  Gas chromatographic analysis of amines and other compounds produced by several species of Clostridium. , 1969, Canadian journal of microbiology.

[34]  F. Volkmar,et al.  Handbook of Autism and Pervasive Developmental Disorders , 1987 .

[35]  J. Mellanby,et al.  Long‐term changes in hippocampal physiology and learning ability of rats after intrahippocampal tetanus toxin. , 1985, The Journal of physiology.

[36]  B. Poulain.  [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins]. , 1994, Pathologie-biologie.

[37]  M. P. Jackson,et al.  Evaluation of a technique for identification of Shiga-like toxin-producing Escherichia coli by using polymerase chain reaction and digoxigenin-labeled probes , 1993, Journal of clinical microbiology.

[38]  A. Salim,et al.  Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. , 1985, British medical journal.

[39]  A. Torres,et al.  Decreased plasma concentrations of the C4B complement protein in autism. , 1994, Archives of pediatrics & adolescent medicine.

[40]  T. Bleck.  Tetanus: pathophysiology, management, and prophylaxis. , 1991, Disease-a-month : DM.

[41]  S. Holmberg,et al.  Drug-resistant Salmonella from animals fed antimicrobials. , 1984, The New England journal of medicine.

[42]  D. N. Currie,et al.  Development of Thy-1 antigen on cerebellar neurons in culture , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  B. Freeman.  The syndrome of autism: Update and guidelines for diagnosis , 1993 .

[44]  T. Kemper,et al.  The contribution of neuropathologic studies to the understanding of autism. , 1993, Neurologic clinics.

[45]  H. Peterson.  A CASE OF TETANUS IN SPITE OF ACTIVE TOXOID PROPHYLAXIS. , 1965, Acta chirurgica Scandinavica.

[46]  M. Schachner,et al.  Developmental expression of cell type-specific markers in mouse cerebellar cells in vitro , 1981, Journal of Neuroimmunology.

[47]  A. A. Miles,et al.  Topley and Wilson's Principles of Bacteriology and Immunity , 1946, The Indian Medical Gazette.

[48]  A. Scheibel,et al.  Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. , 1986, The American journal of psychiatry.

[49]  M. Bohnhoff,et al.  Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. , 1962, The Journal of infectious diseases.

[50]  J. Brown,et al.  Immunodiagnosis and immunotherapy of tetanus and botulinum neurotoxins. , 1995, Current topics in microbiology and immunology.

[51]  N. Bruneau,et al.  Urinary free and conjugated catecholamines and metabolites in autistic children , 1988, Journal of autism and developmental disorders.

[52]  M. Coleman.  Young children with autism or autistic-like behavior , 1989 .

[53]  E. Neale,et al.  Neurospecific binding, internalization, and retrograde axonal transport. , 1995, Current topics in microbiology and immunology.

[54]  J. Wigginton,et al.  Infant Botulism , 1993 .

[55]  M. Schachner,et al.  Maintenance of immunocytologically identified Purkinje cells from mouse cerebellum in monolayer culture , 1984, Brain Research.

[56]  A. Henschen,et al.  Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites. , 1991, European journal of biochemistry.

[57]  D. Stevens,et al.  Role of θ Toxin, a Sulfhydryl-Activated Cytolysin, in the Pathogenesis of Clostridial Gas Gangrene , 1993 .

[58]  E. Cook.  Autism: Review of neurochemical investigation , 1990, Synapse.

[59]  C. Hatheway.  Botulism: the present status of the disease. , 1995, Current topics in microbiology and immunology.

[60]  F. Meier,et al.  Host defense factors in the gastrointestinal tract , 1986, Pediatric infectious disease.

[61]  A. Baker.  THE CENTRAL NERVOUS SYSTEM IN TETANUS , 1942 .

[62]  J. Beitchman,et al.  Child Psychiatry and Early Intervention: III. The Developmental Disorders* , 1992, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[63]  G. Fischer,et al.  Otogenous tetanus: a sequelae of chronic ear infections. , 1977, American journal of diseases of children.

[64]  G. M. Goodwin,et al.  A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5‐HT1 and 5‐HT2 receptors , 1985, British journal of pharmacology.

[65]  G. Nisticó,et al.  Glutamate transmission is involved in the mechanisms of neuronal degeneration produced by intrahippocampal tetanus toxin in rats. , 1992, Toxicology letters.

[66]  W. Walker,et al.  Development of Gastrointestinal Mucosal Barrier. I. The Effect of Age on Intestinal Permeability to Macromolecules , 1981, Pediatric Research.

[67]  Smith,et al.  Introduction to the Pathogenic Anaerobes. , 1955 .

[68]  N. Bowery,et al.  Effect of tetanus toxin on basal and evoked release of 5-hydroxytryptamine and dopamine in rat hippocampus in vivo , 1995, Brain Research.

[69]  W. Shaw,et al.  Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. , 1995, Clinical chemistry.

[70]  J. Fermanian,et al.  Catecholamines metabolism in infantile autism: A controlled study of 22 autistic children , 1987, Journal of autism and developmental disorders.

[71]  D. Hentges.  The protective function of the indigenous intestinal flora , 1986, Pediatric infectious disease.

[72]  G. Kryzhanovsky,et al.  The stereotyped behavior syndrome: A new model and proposed therapy , 1981, Pharmacology Biochemistry and Behavior.

[73]  C. Gillberg,et al.  Epilepsy in autism and autisticlike conditions. A population-based study. , 1988, Archives of neurology.

[74]  B. Andersen,et al.  Clinical tetanus despite a protective level of toxin-neutralizing antibody. , 1986, JAMA.

[75]  T. Kemper,et al.  Histoanatomic observations of the brain in early infantile autism , 1985, Neurology.

[76]  H. Shirai,et al.  Detection of cholera toxin gene in stool specimens by polymerase chain reaction: comparison with bead enzyme-linked immunosorbent assay and culture method for laboratory diagnosis of cholera , 1993, Journal of clinical microbiology.

[77]  M. Mary Konstantareas,et al.  Brief report: Ear infections in autistic and normal children , 1987 .

[78]  G. Nisticó,et al.  Tetanus toxin as a neurobiological tool to study mechanisms of neuronal cell death in the mammalian brain. , 1994, Pharmacology & therapeutics.

[79]  C. Montecucco,et al.  Mechanism of action of tetanus and botulinum neurotoxins , 1994, Molecular microbiology.

[80]  J. T. Erichsen,et al.  Retrograde transneuronal transport properties of fragment C of tetanus toxin , 1990, Neuroscience.

[81]  P. Gumerlock,et al.  Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reaction. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  Y. Kanai,et al.  Antagonism of gamma-aminobutyric acidA receptor-mediated responses by amino-gamma-carbolines. , 1990, The Journal of pharmacology and experimental therapeutics.

[83]  C. Eisele,et al.  Experimental human salmonellosis. I. Pathogenicity of strains of Salmonella meleagridis and Salmonella anatum obtained from spray-dried whole egg. , 1951, The Journal of infectious diseases.

[84]  C. U. M. Smith,et al.  Elements of molecular neurobiology , 1989 .

[85]  G. Collingridge,et al.  Rapid behavioural and biochemical effects of tetanus toxin microinjected into the substantia nigra: A dual role for GABA? , 1979, Neuroscience Letters.

[86]  E. Potorac,et al.  Contributions to the taxonomy and biology of Clostridium difficile. , 1992, Roumanian archives of microbiology and immunology.

[87]  G. Ahnert-Hilger,et al.  Molecular aspects of tetanus and botulinum neurotoxin poisoning , 1995, Progress in Neurobiology.

[88]  C. Cox,et al.  Effect of Tetanolysin on Platelets and Lysosomes , 1974, Infection and immunity.

[89]  L. Levine,et al.  Tetanus despite preexisting antitetanus antibody. , 1978, JAMA.

[90]  L. Kanner.  Autistic disturbances of affective contact. , 1968, Acta paedopsychiatrica.

[91]  K. Fischbeck,et al.  Chronic tetanus: Clinical report and histochemistry of muscle , 1981, Muscle & nerve.

[92]  A. Gordon.  Ear disorders in autistic children , 1989, Journal of autism and developmental disorders.

[93]  C. Eisele,et al.  Experimental human salmonellosis. III. Pathogenicity of strains of Salmonella newport, Salmonella derby, and Salmonella bareilly obtained from spray-dried whole egg. , 1951, The Journal of infectious diseases.

[94]  William Burrows,et al.  Burrows Textbook of microbiology , 1985 .

[95]  H. Sugiyama,et al.  Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores , 1978, Infection and immunity.

[96]  A. Palmer,et al.  Tetanolysin: in-vivo effects in animals. , 1971, The Journal of infectious diseases.

[97]  Nancy J. Minshew,et al.  A preliminary 31P MRS study of autism: Evidence for undersynthesis and increased degradation of brain membranes , 1993, Biological Psychiatry.

[98]  K. Reichelt,et al.  Dietary intervention in autistic syndromes. , 1990 .

[99]  J. Boucher,et al.  Memory impairments and communication in relatively able autistic children. , 1989, Journal of child psychology and psychiatry, and allied disciplines.

[100]  C. Pingree,et al.  Increased frequency of the null allele at the complement C4b locus in autism , 1991, Clinical and experimental immunology.

[101]  C. Gillberg,et al.  Biology of the Autistic Syndromes , 1994 .